| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI116915 |
| P8608 | Fatcat ID | release_hknr3o74bzenzjrnu2kkdgyi6a |
| P932 | PMC publication ID | 288496 |
| P698 | PubMed publication ID | 8254047 |
| P50 | author | Winfried März | Q21153026 |
| P2093 | author name string | Berg A | |
| Buxbaum S | |||
| Pohl T | |||
| Scharnagl H | |||
| Schaaf L | |||
| Baumstark MW | |||
| Russ A | |||
| Herwig J | |||
| Ruzicka V | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100 | Q24316428 | ||
| Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins. | Q33688317 | ||
| Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors | Q33848680 | ||
| Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding | Q34350695 | ||
| Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia | Q34506656 | ||
| Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins | Q34528739 | ||
| Human liver apolipoprotein B-100 cDNA: complete nucleic acid and derived amino acid sequence | Q36458589 | ||
| Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19 | Q36795706 | ||
| Lipolysis Produces Changes in the Immunoreactivity and Cell Reactivity of Very Low Density Lipoproteins | Q37017186 | ||
| Radioimmunoassay studies of human apolipoprotein E. | Q37026434 | ||
| Recent progress in understanding apolipoprotein B. | Q37602213 | ||
| Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia | Q38026771 | ||
| The molecular and cell biology of apolipoprotein-B. | Q38669547 | ||
| Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. | Q39241463 | ||
| Role of apolipoprotein E in lipoprotein metabolism | Q39756701 | ||
| Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease | Q39756771 | ||
| Radioimmunoassay of arginine-rich apolipoprotein of rat serum | Q40047120 | ||
| Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts | Q40189841 | ||
| Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia | Q41174952 | ||
| Mapping apolipoprotein B on the low density lipoprotein surface by immunoelectron microscopy | Q41509122 | ||
| Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor | Q41658312 | ||
| Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function | Q41686669 | ||
| Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins | Q41757752 | ||
| Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100 | Q43602646 | ||
| Cellular metabolism of human plasma intermediate-density lipoprotein (IDL). | Q44031244 | ||
| The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B. | Q44051920 | ||
| Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. | Q44689759 | ||
| Structure of human low-density lipoprotein subfractions, determined by X-ray small-angle scattering | Q45000441 | ||
| Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 | ||
| Familial combined hyperlipidaemia linked to the apolipoprotein AI–CIII–AIV gene cluster on chromosome 11q23q–q24 | Q59054538 | ||
| Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases | Q61560931 | ||
| Apolipoprotein E mediates uptake of Sf 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts | Q67277065 | ||
| Familial defective apolipoprotein B-100: mild hypercholesterolaemia without atherosclerosis in a homozygous patient | Q67523912 | ||
| Detection of the apoB-3500 mutation (glutamine for arginine) by gene amplification and cleavage with MspI | Q67703254 | ||
| Apolipoprotein B(Arg3500----Gln) allele specific polymerase chain reaction: large-scale screening of pooled blood samples | Q67927774 | ||
| Enhanced metabolism of normolipidemic human plasma very low density lipoprotein in cultured cells by exogenous apolipoprotein E-3 | Q67967629 | ||
| 13C NMR evidence that substitution of glutamine for arginine 3500 in familial defective apolipoprotein B-100 disrupts the conformation of the receptor-binding domain | Q68194250 | ||
| Apolipoprotein B gene mutations in Austrian subjects with heart disease and their kindred | Q68293044 | ||
| Radioiodination of proteins and lipoproteins using N-bromosuccinimide as oxidizing agent | Q68429528 | ||
| Isolation and characterization of apolipoprotein E | Q69553515 | ||
| Phenotyping of apolipoprotein E by immunoblotting in immobilized pH gradients | Q70188250 | ||
| 19 Receptor-mediated endocytosis of low-density lipoprotein in cultured cells | Q70193016 | ||
| A 13C NMR characterization of lysine residues in apolipoprotein B and their role in binding to the low density lipoprotein receptor | Q70402665 | ||
| The metabolism of very low density and intermediate density lipoproteins in patients with familial hypercholesterolaemia | Q70446529 | ||
| Evidence for the distribution of apolipoprotein E between lipoprotein classes in human normocholesterolemic plasma and for the origin of unassociated apolipoprotein E (Lp-E) | Q70471651 | ||
| Apolipoprotein E-enriched lipoprotein subclasses in normolipidemic subjects | Q71073148 | ||
| Determination of lipoprotein(a): evaluation of three methods | Q72895110 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | homozygosity | Q114049690 |
| P304 | page(s) | 2922-2933 | |
| P577 | publication date | 1993-12-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor | |
| P478 | volume | 92 |
| Q59528278 | Angeborene Störungen im Lipoproteinstoffwechsel |
| Q75239559 | Clinical and biochemical characterisation of patients with autosomal recessive hypercholesterolemia (ARH) |
| Q28472676 | Computational lipidology: predicting lipoprotein density profiles in human blood plasma |
| Q44533464 | Differences in clinical presentation between subjects with a phenotype of familial hypercholesterolemia determined by defects in the LDL-receptor and defects in Apo B-100 |
| Q44683254 | Differences in the Phenotypic Characteristics of Subjects With Familial Defective Apolipoprotein B-100 and Familial Hypercholesterolemia |
| Q43812139 | Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells |
| Q49052389 | Evaluation of the Roche Diagnostics LightCycler-Apo B 3500 Mutation Detection Kit. |
| Q41779360 | Familial hypercholesterolaemia |
| Q44327119 | Familial hypercholesterolemia due to ligand-defective apolipoprotein B100: first case report in a Mexican family |
| Q73229414 | Familial ligand-defective apolipoprotein B-100: detection, biochemical features and haplotype analysis of the R3531C mutation in the UK |
| Q31798357 | Frequency of the R3500Q mutation of the apolipoprotein B-100 gene in a sample screened clinically for familial hypercholesterolemia in Hungary |
| Q34800220 | Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs |
| Q40964792 | Low-density lipoprotein heterogeneity |
| Q41571817 | Low-density lipoprotein subclasses: mechanisms of formation and modulation |
| Q28214323 | Statins in homozygous familial hypercholesterolemia |
| Q36353492 | Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity |
| Q57337204 | The apolipoprotein E4 allele is not associated with an abnormal lipid profile in a Native American population following its traditional lifestyle |
| Q40845171 | The effects of lifibrol (K12.148) on the cholesterol metabolism of cultured cells: evidence for sterol independent stimulation of the LDL receptor pathway |
| Q34258208 | The significance of genetic polymorphisms in modulating the response to lipid-lowering drugs |
| Q78004728 | Unusual inheritance of severe primary hypercholesterolemia |
Search more.